186 related articles for article (PubMed ID: 37113223)
1. Aneuploidy enables cross-tolerance to unrelated antifungal drugs in
Sun LL; Li H; Yan TH; Cao YB; Jiang YY; Yang F
Front Microbiol; 2023; 14():1137083. PubMed ID: 37113223
[No Abstract] [Full Text] [Related]
2. Aneuploidy Underlies Tolerance and Cross-Tolerance to Drugs in Candida parapsilosis.
Yang F; Lu H; Wu H; Fang T; Berman J; Jiang YY
Microbiol Spectr; 2021 Oct; 9(2):e0050821. PubMed ID: 34612700
[No Abstract] [Full Text] [Related]
3. Tunicamycin Potentiates Antifungal Drug Tolerance via Aneuploidy in Candida albicans.
Yang F; Gritsenko V; Slor Futterman Y; Gao L; Zhen C; Lu H; Jiang YY; Berman J
mBio; 2021 Aug; 12(4):e0227221. PubMed ID: 34465026
[TBL] [Abstract][Full Text] [Related]
4. Aneuploidy Enables Cross-Adaptation to Unrelated Drugs.
Yang F; Teoh F; Tan ASM; Cao Y; Pavelka N; Berman J
Mol Biol Evol; 2019 Aug; 36(8):1768-1782. PubMed ID: 31028698
[TBL] [Abstract][Full Text] [Related]
5. Echinocandin antifungal drugs in fungal infections: a comparison.
Chen SC; Slavin MA; Sorrell TC
Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
[TBL] [Abstract][Full Text] [Related]
6. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 1 trisomy confers resistance to aureobasidin A in
Zheng L; Xu Y; Dong Y; Ma X; Wang C; Yang F; Guo L
Front Microbiol; 2023; 14():1128160. PubMed ID: 37007527
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of
Yang F; Zhang L; Wakabayashi H; Myers J; Jiang Y; Cao Y; Jimenez-Ortigosa C; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223384
[TBL] [Abstract][Full Text] [Related]
9. Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity.
Gil-Alonso S; Quindós G; Cantón E; Eraso E; Jauregizar N
Rev Iberoam Micol; 2019; 36(1):24-29. PubMed ID: 30837186
[TBL] [Abstract][Full Text] [Related]
10. Exploring the In Vitro Resistance of Candida parapsilosis to Echinocandins.
Chassot F; Venturini TP; Piasentin FB; Rossato L; Fiorini A; Svidzinski TI; Alves SH
Mycopathologia; 2016 Oct; 181(9-10):663-70. PubMed ID: 27318852
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of nikkomycin Z with caspofungin and micafungin against Candida albicans and Candida parapsilosis biofilms.
Kovács R; Nagy F; Tóth Z; Bozó A; Balázs B; Majoros L
Lett Appl Microbiol; 2019 Oct; 69(4):271-278. PubMed ID: 31385615
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough invasive candidiasis in patients on micafungin.
Pfeiffer CD; Garcia-Effron G; Zaas AK; Perfect JR; Perlin DS; Alexander BD
J Clin Microbiol; 2010 Jul; 48(7):2373-80. PubMed ID: 20421445
[TBL] [Abstract][Full Text] [Related]
13. Decreased echinocandin susceptibility in
Ning Y; Xiao M; Perlin DS; Zhao Y; Lu M; Li Y; Luo Z; Dai R; Li S; Xu J; Liu L; He H; Liu Y; Li F; Guo Y; Chen Z; Xu Y; Sun T; Zhang L
Emerg Microbes Infect; 2023 Dec; 12(1):2153086. PubMed ID: 36440795
[No Abstract] [Full Text] [Related]
14. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
Kritikos A; Neofytos D; Khanna N; Schreiber PW; Boggian K; Bille J; Schrenzel J; Mühlethaler K; Zbinden R; Bruderer T; Goldenberger D; Pfyffer G; Conen A; Van Delden C; Zimmerli S; Sanglard D; Bachmann D; Marchetti O; Lamoth F;
Clin Microbiol Infect; 2018 Nov; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
[TBL] [Abstract][Full Text] [Related]
15. Use of epidemiological cutoff values to examine 9-year trends in susceptibility of Candida species to anidulafungin, caspofungin, and micafungin.
Pfaller M; Boyken L; Hollis R; Kroeger J; Messer S; Tendolkar S; Diekema D
J Clin Microbiol; 2011 Feb; 49(2):624-9. PubMed ID: 21147948
[TBL] [Abstract][Full Text] [Related]
16. Improved detection of Candida sp. fks hot spot mutants by using the method of the CLSI M27-A3 document with the addition of bovine serum albumin.
Garcia-Effron G; Park S; Perlin DS
Antimicrob Agents Chemother; 2011 May; 55(5):2245-55. PubMed ID: 21383097
[TBL] [Abstract][Full Text] [Related]
17. Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibility.
Dimopoulou D; Hamilos G; Tzardi M; Lewis RE; Samonis G; Kontoyiannis DP
Antimicrob Agents Chemother; 2014; 58(1):229-36. PubMed ID: 24145540
[TBL] [Abstract][Full Text] [Related]
18. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.
Pfaller MA; Diekema DJ; Andes D; Arendrup MC; Brown SD; Lockhart SR; Motyl M; Perlin DS;
Drug Resist Updat; 2011 Jun; 14(3):164-76. PubMed ID: 21353623
[TBL] [Abstract][Full Text] [Related]
19. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
Pfaller MA; Messer SA; Woosley LN; Jones RN; Castanheira M
J Clin Microbiol; 2013 Aug; 51(8):2571-81. PubMed ID: 23720791
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2008 Jan; 46(1):150-6. PubMed ID: 18032613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
